CoChat

Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study

Open access
Carrat, Fabrice, de Lamballerie, Xavier, Rahib, Delphine, Blanché, Hélène, Lapidus, Nathanael, Artaud, Fanny, Kab, Sofiane, Renuy, Adeline, Szabo de Edelenyi, Fabien, Meyer, Laurence, Lydié, Nathalie, Charles, Marie-Aline, Ancel, Pierre-Yves, Jusot, Florence, Rouquette, Alexandra, Priet, Stéphane, Saba Villarroel, Paola Mariela, Fourié, Toscane, Lusivika-Nzinga, Clovis, Nicol, Jérôme, Legot, Stephane, Druesne-Pecollo, Nathalie, Esseddik, Younes, Lai, Cindy, Gagliolo, Jean-Marie, Deleuze, Jean-François, Bajos, Nathalie, Severi, Gianluca, Touvier, Mathilde, Zins, Marie, for the SAPRIS and SAPRIS-SERO study groups · 2021 · International Journal of Epidemiology
Cited by 138

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background: We aimed to estimate the seropositivity to anti-SARS-CoV-2 antibodies in May–June 2020 after the first lockdown period in adults living in three regions in France and to identify the associated risk factors. Methods: Between 4 May 2020 and 23 June 2020, 16 000 participants in a survey on COVID-19 from an existing consortium of three general adult population cohorts living in the Ile-de-France (IDF) or Grand Est (GE) (two regions with high rate of COVID-19) or in the Nouvelle-Aquitaine (NA) (with a low rate) were randomly selected to take a dried-blood spot for anti-SARS-CoV-2 antibodies assessment with three different serological methods (ClinicalTrial Identifier #NCT04392388). The primary outcome was a positive anti-SARS-CoV-2 ELISA IgG result against the spike protein of the virus (ELISA-S). Estimates were adjusted using sampling weights and post-stratification methods. Multiple imputation was used to infer the cumulative incidence of SARS-CoV-2 infection with adjustments for imperfect tests accuracies. Results: The analysis included 14 628 participants, 983 with a positive ELISA-S. The weighted estimates of seropositivity and cumulative incidence were 10.0% [95% confidence interval (CI): 9.1%, 10.9%] and 11.4% (95% CI: 10.1%, 12.8%) in IDF, 9.0% (95% CI: 7.7%, 10.2%) and 9.8% (95% CI: 8.1%, 11.8%) in GE and 3.1% (95% CI: 2.4%, 3.7%) and 2.9% (95% CI: 2.1%, 3.8%) in NA, respectively. Seropositivity was higher in younger participants [odds ratio (OR) = 1.84 (95% CI: 1.79, 6.09) in <40 vs 50–60 years old and OR = 0.56 (95% CI: 0.42, 0.74) in ≥70 vs 50–60 years old)] and when at least one child or adolescent lived in the same household [OR = 1.30 (95% CI: 1.11, 1.53)] and was lower in smokers compared with non-smokers [OR = 0.71 (95% CI: 0.57, 0.89)]. Conclusions: Seropositivity to anti-SARS-CoV-2 antibodies in the French adult population was ≤10% after the first wave. Modifiable and non-modifiable risk factors were identified.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ije/dyab110

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 138

Metadata

Authors
Carrat, F., de Lamballerie, X., Rahib, D., Blanché, H., Lapidus, N., Artaud, F., Kab, S., Renuy, A., Szabo de Edelenyi, F., Meyer, L., Lydié, N., Charles, M.-A., Ancel, P.-Y., Jusot, F., Rouquette, A., Priet, S., Saba Villarroel, P. M., Fourié, T., Lusivika-Nzinga, C., Nicol, J., Legot, S., Druesne-Pecollo, N., Esseddik, Y., Lai, C., Gagliolo, J.-M., Deleuze, J.-F., Bajos, N., Severi, G., Touvier, M., Zins, M., & groups, F. T. S. A. S.-S. S.
Venue
International Journal of Epidemiology
Published
2021-07-19
Volume
50
Issue
5
Pages
1458-1472
ISSN
  • 0300-5771 (ISSN-L)
  • 1464-3685
OpenAlex
W3186203403
Cited by
138
References
9
FWCI
8.74
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study. https://app.cochat.ai/papers/10.1093/ije/dyab110
The paper
Carrat, F., de Lamballerie, X., Rahib, D., Blanché, H., Lapidus, N., Artaud, F., Kab, S., Renuy, A., Szabo de Edelenyi, F., Meyer, L., Lydié, N., Charles, M.-A., Ancel, P.-Y., Jusot, F., Rouquette, A., Priet, S., Saba Villarroel, P. M., Fourié, T., Lusivika-Nzinga, C., . . . groups, F. T. S. A. S.-S. S. (2021). Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyab110

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.